Agency
Scheidler Medical Preferred, LLC
Scheidler Medical Preferred, LLC was paid $2.16M by Medicaid between Jan 2018 and Dec 2024, across 54 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 72% of everything it billed.
33Billing provider infoSCHEIDLER MEDICAL PREFERRED, LLC
HAMILTON, OH 45013
HAMILTON, OH 45013
33aNPI1780935254assigned 09/25/2012
33bProvider typeCommunity/Behavioral Health Agency
28Total paid$2.16M
24GClaims73,299
24DCodes billed54
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community/Behavioral Health Agency providers in Ohio
Rank by total paid#125 of 417
Median peer was paid$469K
This provider vs. median4.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,213 | $337K | |
| 2019 | 9,231 | $257K | |
| 2020 | 11,868 | $370K | |
| 2021 | 13,680 | $464K | |
| 2022 | 11,162 | $335K | |
| 2023 | 8,886 | $212K | |
| 2024incomplete | 7,259 | $185K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 72% | 30,298 | 24,791 | $1.56M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.0% | 5,542 | 4,944 | $195K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.1% | 1,461 | 1,370 | $110K |
| 80305 | 4.1% | 11,332 | 10,068 | $88K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.6% | 5,433 | 4,708 | $56K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.8% | 562 | 282 | $38K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 3,977 | 3,447 | $14K |
| 20610 | <1% | 444 | 354 | $14K | |
| 82947 | <1% | 5,979 | 4,846 | $12K | |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 215 | 163 | $10K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 847 | 743 | $8K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 598 | 529 | $7K |
42 more codes
| J3490 | Unclassified drugs | <1% | 1,769 | $7K |
| 90688 | <1% | 518 | $6K | |
| 20552 | <1% | 144 | $5K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 47 | $4K |
| 96127 | <1% | 1,009 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 215 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 82 | $2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 414 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 259 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 33 | $2K |
| 94010 | <1% | 133 | $2K | |
| 0011A | <1% | 44 | $1K | |
| 94060 | <1% | 41 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 50 | $1K |
| 81002 | <1% | 604 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 88 | $990.01 |
| 0012A | <1% | 25 | $860.26 | |
| 20551 | <1% | 36 | $832.75 | |
| 72110 | <1% | 27 | $787.84 | |
| 90686 | <1% | 64 | $693.60 | |
| 72100 | <1% | 29 | $586.50 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 13 | $541.68 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 62 | $419.92 |
| 20553 | <1% | 15 | $416.38 | |
| 73560 | <1% | 13 | $251.04 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 175 | $188.72 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16 | $165.54 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 115 | $137.23 |
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | <1% | 14 | $111.40 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 58 | $107.18 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 99 | $88.85 |
| 82570 | <1% | 17 | $32.45 | |
| A7010 | Corrugated tubing, disposable, used with large volume nebulizer, 100 feet | <1% | 123 | $29.29 |
| G0008 | Administration of influenza virus vaccine | <1% | 21 | $24.17 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 14 | $18.65 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 15 | $4.91 |
| J2315 | Injection, naltrexone, depot form, 1 mg | <1% | 40 | $3.26 |
| 91301 | <1% | 111 | $0.95 | |
| 91306 | <1% | 15 | $0.10 | |
| G0247 | Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails | 0% | 15 | $0.00 |
| 99000 | 0% | 17 | $0.00 | |
| 94760 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHUBBARD, KATHY (PRACTICE MANAGER)